530 patients have avoided the need for an invasive angiogram as a result of our commitment to spread the Innovation and Technology Payment (ITP) programme procedure – HeartFlow.
HeartFlow is a non-invasive procedure that creates a personalised 3D model of the coronary arteries and analyses the impact that blockages have on blood flow.
Hull University Teaching Hospitals NHS Trust and Sheffield Teaching Hospitals NHS Foundation Trust have reported 165 uses to NHS England which predicts a 55% reduction in patients who would otherwise have received this treatment. NHS savings of over £163,000 have been made as a result based on the NHS tariff.
The hospitals have seen reduced waiting times for diagnostic tests of coronary heart disease, and we have achieved our overall spread target for this year with the sites in Hull, Sheffield and most recently, Leeds, now ‘live’ and using the new procedure.
Heartflow enables clinicians to identify significant coronary artery disease and determine the optimal treatment pathway thereby significantly cutting health care costs and leading to improved patient experiences and quality of life. Statistics show that more than half of patients who undergo invasive angiogram tests have no significant coronary blockage.